# Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers

> **NCT01796431** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 18 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Eviplera®

## Key facts

- **NCT ID:** NCT01796431
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796431, "Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01796431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*